Pictet Asset Management’s Wave Life Sciences WVE Stock Holding History
Bought
Maintained
Sold
Other funds holding WVE
RCM
GP
MC
DCM
6CM
RAM
Pictet Asset Management's WVE Position: Q2 2026 in Review
Pictet Asset Management reduced its Wave Life Sciences (WVE) stake by 20% in Q2 2026, selling an estimated $1.54M and leaving 917,409 shares worth $5.33M. The position accounts for 0.01% of the portfolio, ranked #797.
Pictet Asset Management first reported a position in WVE in Q2 2024 and has held it in 9 quarters since. The position peaked at $13.8M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.
- Pictet Asset Management held 917,409 shares of Wave Life Sciences worth $5.33M as of Q2 2026.
- Pictet Asset Management sold 231,718 Wave Life Sciences shares in Q2 2026, an estimated $1.54M.
- Wave Life Sciences made up 0.01% of Pictet Asset Management's portfolio in Q2 2026, its #797 holding.
- Pictet Asset Management first reported a position in Wave Life Sciences in Q2 2024 and has held it in 9 quarters since.
- Pictet Asset Management's Wave Life Sciences position peaked at $13.8M in Q4 2025.
- 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.
Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.